Webinars and Sponsored Roundtables — Register Now
Tuesday, June 9, 2026, 1:00–2:00 PM ET
In this webinar, we will examine how immune recognition after allogeneic HCT can influence leukemia relapse and disease progression. The session will highlight the clinical relevance of HLA loss of heterozygosity (LOH), approaches used for its detection, and how LOH findings may support transplant strategies, including considerations for donor selection in subsequent transplantation.
Webinar presenter Alberto Cardoso Martins Lima, PhD, Clinical consulting scientist in histocompatibility,
specializing in allogeneic hematopoietic cell transplantation (HCT) at IGEN/AFIP São Paulo and CHC/UFPR in Curitiba, Brazil
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Wednesday, June 24, 2026, 12:00–1:00 PM ET
Hear an expert discuss the expanded clinical utility of HER2 IHC scoring in metastatic breast cancer and its impact on your practice
Webinar presenter Michelle Shiller, DO, AP, CP, MGP, FACP, Baylor University Medical Center.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Wednesday, July 15, 2026, 1:00-2:00 PM ET
Hear an expert discuss how to integrate Kappa and Lambda in situ hybridization testing into your standard hematopathology workflow to accurately assess B-cell and plasma cell clonality. You will also gain the skills to recognize testing pitfalls in challenging reactive versus neoplastic proliferations and apply ancillary tools to resolve complex cases.
Webinar presenter Xiaojun Wu, MD, PhD, Assistant professor, Director of Hematopathology Section at NCR of Johns Hopkins Medicine Department of Pathology, SOM at Johns Hopkins University
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Subspecialties
Interactive Product Guides
2026 Tutorial on Neoplastic Hematopathology
Event Details
The Tutorial on Neoplastic Hematopathology began over 50 years ago by Dr. Henry Rappaport while at the University of Chicago. The course continues to update participants on the latest on pathology of hematologic malignancies presented by the leading faculty in the field. After 25 years of outstanding leadership from Dr. Daniel Knowles and Weill Cornell Medicine, the tutorial is now directed by Dr. Daniel Arber at the University of Chicago. Under Dr. Arber’s leadership, the course remains committed to providing participants with the most up-to-date information. In 2023, the course was revised to focus on the new lymphoma classifications and includes speakers involved in both the International Consensus Classification and the new and prior World Health Organization Classifications.
CONFERENCE DESCRIPTION
Continuing in the tradition of 40+years of tutorials, the2026 course is designed to update physicians on the latest advances in neoplastic hematopathology. It will be conducted under the direction of Dr. Daniel A. Arber at the Hyatt Regency Phoenix Hotel from January18–22,2026. The program will consist of lectures, case presentations, and discussions designed to provide pathologists, pathologists-in-training, and medical oncologists/ hematologists with an in-depth discussion of diagnostic problems that arise in neoplastic hematopathology.